Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control.

Kuwabara M, Hamano T, Ae R

Open source

DOI
10.1038/s41440-026-02756-9
Published
2026 Aug 13
Container
Hypertension research : official journal of the Japanese Society of Hypertension
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41440-026-02756-9,
  title = {Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control.},
  author = {Kuwabara M and Hamano T and Ae R},
  year = {2026},
  journal = {Hypertension research : official journal of the Japanese Society of Hypertension},
  doi = {10.1038/s41440-026-02756-9},
  url = {https://doi.org/10.1038/s41440-026-02756-9}
}

RIS

TY  - JOUR
TI  - Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control.
AU  - Kuwabara M
AU  - Hamano T
AU  - Ae R
PY  - 2026
JO  - Hypertension research : official journal of the Japanese Society of Hypertension
DO  - 10.1038/s41440-026-02756-9
UR  - https://doi.org/10.1038/s41440-026-02756-9
ER  - 

APA

M, K., T, H., & R, A. (2026). Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control.. Hypertension research : official journal of the Japanese Society of Hypertension. https://doi.org/10.1038/s41440-026-02756-9

Source records